Dongkook Lifescience has agreed to collaborate with the Korean Society of Thoracic Radiology to enhance the expertise of thoracic radiology and advance patient-centered medical care.


Dongkook Lifescience Signs MOU with Korean Society of Thoracic Radiology: "Enhancing Expertise" View original image

On May 11, Dongkook Lifescience announced that it had signed a memorandum of understanding (MOU) with the Korean Society of Thoracic Radiology. Through this agreement, the two organizations plan to establish a cooperative framework for academic advancement and improvement of medical services in the field of thoracic radiology, and to continuously explore various collaborative measures that can contribute to greater expertise and the realization of patient-centered care.


The Korean Society of Thoracic Radiology is a leading academic organization that has contributed to the advancement of patient-centered medicine through research, education, and the promotion of multidisciplinary collaboration in the field of thoracic radiology. With this agreement, it is expected that the collaborative foundation between industry and academia will be further strengthened.


Dongkook Lifescience, leveraging its expertise in medical imaging diagnostics, has strived to advance the medical field and realize patient-centered values. The company plans to actively participate in the ongoing development of thoracic radiology and the improvement of the medical environment through this agreement.



A representative from Dongkook Lifescience stated, "This agreement with the Korean Society of Thoracic Radiology is more than a simple business partnership—it is a meaningful starting point for the advancement of thoracic radiology in Korea and the realization of patient-centered care. We will continue our efforts to provide practical support to the medical field through academic exchange and collaboration."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing